Safety of ESAT-6

Tuberculosis

Volumn 86, Issue 5, 2006, Pages 363-373

  Aggerbeck, Henrik ^a   Madsen, Søren M ^b  

^a STATENS SERUM INSTITUT   (Denmark)

^b BIONEER A S   (Denmark)

Author keywords

ESAT 6; Lactococcus expression; Safety; Tuberculosis

Indexed keywords

EARLY SECRETORY ANTIGENIC TARGET 6; T LYMPHOCYTE ANTIGEN; TUBERCULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DOG; DRUG SAFETY; FEMALE; GUINEA PIG; IN VIVO STUDY; MALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; TUBERCULIN TEST;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; DOGS; FEMALE; GUINEA PIGS; HYPERSENSITIVITY, DELAYED; MALE; MICE; MYCOBACTERIUM TUBERCULOSIS; RATS; RECOMBINANT PROTEINS; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS;

EID: 33746893009     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2005.08.020     Document Type: Article

References (40)

1. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 161 4, Part 1 (2000) 1376-1395
2. Huebner R.E., Schein M.F., and Bass Jr. J.B. The tuberculin skin test. Clin Infect Dis 17 6 (1993) 968-975
3. American Thoracic Society. The tuberculin skin test. Am Rev Respir Dis 124 (1981) 356-363
4. Sorensen A.L., Nagai S., Houen G., Andersen P., and Andersen A.B. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 63 5 (1995) 1710-1717
5. Andersen P., Andersen A.B., Sorensen A.L., and Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 154 7 (1995) 3359-3372
6. Harboe M., Oettinger T., Wiker H.G., Rosenkrands I., and Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 64 1 (1996) 16-22
7. Gey van Pittius N.C., Gamieldien J., Hide W., Brown G.D., Siezen R.J., and Beyers A.D. The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram positive bacteria. Genome Biol 2 10 (2001) 1-18
8. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., and Stover C.K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178 5 (1996) 1274-1282
9. Mostowy S., Tsolaki A.G., Small P.M., and Behr M.A. The in vitro evolution of BCG vaccines. Vaccine 21 27-30 (2003) 4270-4274
10. Renshaw P.S., Panagiotidou P., Whelan A., Gordon S.V., Hewinson R.G., and Williamson R.A. Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10 and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence. J Biol Chem 277 24 (2002) 21598-21603
11. Hsu T., Hingley-Wilson S.M., Chen B., Chen M., Dai A.Z., and Morin P.M. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci USA 100 21 (2003) 12420-12425
12. Guinn K.M., Hickey M.J., Mathur S.K., Zakel K.L., Grotzke J.E., and Lewinsohn D.M. Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol 51 2 (2004) 359-370
13. Stanley S.A., Raghavan S., Hwang W.W., and Cox J.S. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci USA 100 22 (2003) 13001-13006
14. Gao L.Y., Guo S., McLaughlin B., Morisaki H., Engel J.N., and Brown E.J. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol Microbiol 53 6 (2004) 1677-1693
15. Pym A.S., Brodin P., Majlessi L., Brosch R., Demangel C., and Williams A. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9 5 (2003) 533-539
16. van Pinxteren L.A., Ravn P., Agger E.M., Pollock J., and Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 7 2 (2000) 155-160
17. Andersen P., Munk M.E., Pollock J.M., and Doherty T.M. Specific immune-based diagnosis of tuberculosis. Lancet 356 9235 (2000) 1099-1104
18. Elhay M.J., Oettinger T., and Andersen P. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect Immun 66 7 (1998) 3454-3456
19. Pollock J.M., McNair J., Bassett H., Cassidy J.P., Costello E., and Aggerbeck H. Specific delayed-type hypersensitivity responses to ESAT-6 identify tuberculosis-infected cattle. J Clin Microbiol 41 5 (2003) 1856-1860
20. Brock I., Weldingh K., Lillebaek T., Follmann F., and Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 170 1 (2004) 65-69
21. Ewer K., Deeks J., Alvarez L., Bryant G., Andersen P., and Monk P. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361 9364 (2003) 1168-1173
22. Gasson M.J. Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol 154 1 (1983) 1-9
23. Madsen S.M., Arnau J., Vrang A., Givskov M., and Israelsen H. Molecular characterization of the pH-inducible and growth phase-dependent promoter P170 of Lactococcus lactis. Mol Microbiol 32 1 (1999) 75-87
24. van Asseldonk M., Rutten G., Oteman M., Siezen R.J., de Vos W.M., and Simons G. Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. Gene 95 1 (1990) 155-160
25. Reece S.T., Stride N., Ovendale P., Reed S., and Campos-Neto A. Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigs. Infect Immun 73 6 (2005) 3301-3306
26. Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76 2 (1994) 287-299
27. Sant'Angelo D.B., Robinson E., Janeway Jr. C.A., and Denzin L.K. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor. Eur J Immunol 32 9 (2002) 2510-2520
28. Daniel T.M. The immunology of tuberculosis. Clin Chest Med 1 2 (1980) 189-201
29. Magnusson M., and Bentzon M.W. Preparation of purified tuberculin RT 23. Bull World Health Organ 19 (1958) 829-843
30. Mustafa A.S., Shaban F.A., Al Attiyah R., Abal A.T., El Shamy A.M., Andersen P., et al. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand J Immunol 57 2 (2003) 125-134
31. Vincenti D., Carrara S., De Mori P., Pucillo L.P., Petrosillo N., Palmieri F., et al. TI-Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis. Mol Med 9 3-4 (2003) 105-111
32. Vordermeier M., Whelan A.O., and Hewinson R.G. TI-recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes. Infect Immun 71 4 (2003) 1980-1987
33. Bass Jr. J.A., and Serio R.A. The use of repeat skin tests to eliminate the booster phenomenon in serial tuberculin testing. Am Rev Respir Dis 123 4, Part 1 (1981) 394-396
34. Fine P.E., Bruce J., Ponnighaus J.M., Nkhosa P., Harawa A., and Vynnycky E. Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis 3 11 (1999) 962-975
35. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159 1 (1999) 15-21
36. Olsen A.W., Williams A., Okkels L.M., Hatch G., and Andersen P. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 72 10 (2004) 6148-6150
37. Dietrich J., Aagaard C., Leah R., Olsen A.W., Stryhn A., Doherty T.M., et al. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 174 10 (2005) 6332-6339
38. Doherty T.M., Demissie A., Olobo J., Wolday D., Britton S., Eguale T., et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 40 2 (2002) 704-706
39. Arend S.M., van Meijgaarden K.E., de Boer K., de Palou E.C., van Soolingen D., Ottenhoff T.H., et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 186 12 (2002) 1797-1807
40. Cardoso F.L., Antas P.R., Milagres A.S., Geluk A., Franken K.L., Oliveira E.B., et al. T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients. Infect Immun 70 12 (2002) 6707-6714